D-1625-2020 Class III Terminated
FDA drug recall D-1625-2020 was initiated by Arbor Pharmaceuticals Inc. on September 16, 2020 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated February 22, 2022). Affected quantity: 1846 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- October 7, 2020
- Initiation Date
- September 16, 2020
- Termination Date
- February 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1846 cartons
Product Description
Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12
Reason for Recall
Subpotent Drug
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 356884 Exp. 11/30/2021